Hatem Soliman, MD

Dr. Soliman's research focuses on the development of new immunotherapy treatments (vaccines, immune modulating drugs) in the treatment of breast cancer.

• Suanyuk N, Mankhakhet S, Soliman H, Saleh M, El-Matbouli M. Euclinostomum heterostomum infection in guppies Poecilia reticulata cultured in southern Thailand. Dis Aquat Organ. 2013 May;104(2):121-127. Pubmedid: 23709465.
• Soliman H, Rawal B, Fulp J, Lee JH, Lopez A, Bui MM, Khalil F, Antonia S, Yfantis HG, Lee DH, Dorsey TH, Ambs S. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol Immunother. 2013 May;62(5):829-837. Pubmedid: 23344392.
• Soliman H. Immunotherapy strategies in the treatment of breast cancer. Cancer Control. 2013 Jan;20(1):17-21. Pubmedid: 23302903.
• Joh JE, Esposito NN, Kiluk JV, Laronga C, Khakpour N, Soliman H, Catherine Lee M. Pathologic Tumor Response of Invasive Lobular Carcinoma to Neo-adjuvant Chemotherapy. Breast J. 2012 Nov;18(6):569-574. Pubmedid: 23034096.
• Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Soliman H, Somlo G, Theriault RL, Ward JH, Wolff AC, Zellars R, Kumar R, Shead DA. Metastatic Breast Cancer, Version 1.2012: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012 Jul;10(7):821-829. Pubmedid: 22773798.
• Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, Soliman H, Boughey JC, Reynolds C, Lawton TJ, Acs PI, Gordan L, Acs G. The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. Oncologist. 2011;16(11):1520-1526. Pubmedid: 22016474. Pmcid: PMC3233285.
• Soliman H. Developing an effective breast cancer vaccine. Cancer Control. 2010 Jul;17(3):183-190. Pubmedid: 20664516.
• Soliman H, Mediavilla-Varela M, Antonia S. Indoleamine 2,3-dioxygenase: is it an immune suppressor?. Cancer J. 2010 July;16(4):354-359. Pubmedid: 20693847.
• Chiappori AA, Soliman H, Janssen WE, Antonia SJ, Gabrilovich DI. INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect. Expert Opin Biol Ther. 2010 Jun;10(6):983-991. Pubmedid: 20420527. Pmcid: PMC3146364.
• Soliman H, Ferrari A, Thomas D. Sarcoma in the young adult population: an international view. Semin Oncol. 2009 Jun;36(3):227-236. Pubmedid: 19460580.
• Soliman H, Agresta S. Current issues in adolescent and young adult cancer survivorship. Cancer Control. 2008 Jan;15(1):55-62. Pubmedid: 18094661.
• Ling J, Pi W, Bollag R, Zeng S, Keskintepe M, Soliman H, Krantz S, Whitney B, Tuan D. The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol. 2002 Mar;76(5):2410-2423. Pubmedid: 11836419.